Related Experiment Video
Updated: Mar 7, 2026

06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.9K
Detection of Minimally Visible Recurrent Retinoblastoma by Hand-held Spectral-Domain Optical Coherence Tomography
Journal of Pediatric Ophthalmology and Strabismus
|February 15, 2017
Summary
Hand-held spectral-domain optical coherence tomography (SD-OCT) detected subclinical retinoblastoma recurrence missed by standard exams. This imaging tool aids in early detection of recurrent retinoblastoma, improving patient outcomes.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Medical Imaging
Background:
- Retinoblastoma is the most common primary intraocular malignancy in children.
- Early detection and management of recurrent retinoblastoma are crucial for preserving vision and life.
- Standard follow-up methods may not detect minimal residual disease.
Purpose of the Study:
- To evaluate the utility of hand-held spectral-domain optical coherence tomography (SD-OCT) in detecting subclinical recurrence of retinoblastoma.
- To assess the effectiveness of SD-OCT in identifying recurrence within previous regression scars.
Main Methods:
- A case study of a 2-month-old infant with bilateral familial retinoblastoma treated with chemotherapy and focal therapy.
- Follow-up included fundus examination, ultrasonography, and hand-held SD-OCT at 5 months.
- Comparison of findings from different imaging modalities.
Main Results:
- Fundus examination and ultrasonography showed no evidence of recurrence.
- Hand-held SD-OCT revealed subclinical recurrence in a prior regression scar.
- Subsequent treatment resulted in a flat scar, confirming the SD-OCT findings.
Conclusions:
- Hand-held SD-OCT is a valuable tool for detecting subclinical retinoblastoma recurrence.
- SD-OCT can identify residual disease missed by conventional examination methods.
- This technology can improve monitoring and management of retinoblastoma patients.

